Type 2 Diabetes Mellitus Clinical Trial
— LB2Official title:
Linking Self-Management and Primary Care for Diabetes
This project is primarily a behavioral study. We employed a three-arm, patient-randomized
practical effectiveness trial to evaluate the impact of two different interactive,
multimedia self-management programs, relative to "enhanced" usual care. The two
interventions will be (a) the revised program from our present study, based on our
social-ecological theory and the 5 As self-management model, plus enhanced support (ASM+ES)
that includes practical, but extensive, ongoing support and b) largely Automated
Self-Management (ASM). These programs will be compared to a realistic "enhanced usual care"
(UC) condition that will provide health risk appraisal feedback, control for computer
interactions, and provide standardized advice on behavior change, but not the hypothesized
key intervention processes of goal-setting, barriers identification, problem-solving, or
social-environmental support. Patients will be randomized to conditions within clinic and
will participate for 1 year.
The proposed project will test the effectiveness of a practical, automated-based
intervention for primary care patients to facilitate dietary and physical activity
practices, and medication-taking. Analyses will focus on primary outcomes of (a) dietary,
physical activity, medication-taking outcomes, and (b) the UKPDS risk equation as well as
secondary quality-of-life, patient-activation, and patient care outcomes (Specific Aim #2).
Using the RE-AIM measures, we will analyze the reach, effectiveness, adoption,
implementation, and maintenance of the intervention programs (Specific Aim #3), and also
factors related to program implementation, linkage to primary care, and program success with
emphasis on cost, cost-effectiveness, and mediators and moderators of outcomes such as
social-environment support (Aim #4).
Primary hypotheses:
1. That the Automated Intervention received by Automated self-management (ASM) condition
and ASM plus enhanced support conditions (ASM+ES) will be superior to usual care on the
primary outcomes.
2. That the ASM+ES condition will be superior to the ASM alone condition on primary
outcomes at the 12-month follow-up.
| Status | Completed |
| Enrollment | 463 |
| Est. completion date | December 2014 |
| Est. primary completion date | December 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 25 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - Inclusion criteria: - being 25-75 years of age, - live independently, - have a telephone, - are able to read in either English or Spanish, - able to access the Internet at least twice per week - are capable of providing informed consent, - have been diagnosed with type 2 diabetes for at least 1 year - are overweight (BMI = 25), and - have at least one additional UKPDS equation risk factor (i.e., high lipids, hypertension, HbA1c, or smoking) Exclusion Criteria: - Exclusion criteria: - Suffering dementia or active psychosis, - Being on end-stage dialysis, - or predicted to live fewer than 2 years - Being institutionalized. - Pregnant women - women with gestational diabetes will not be enrolled, because there needs are quite different, but we won't specifically exclude women who are pregnant AND otherwise eligible, since we do acknowledge that it's possible that someone may be unaware that they are pregnant at the time of enrollment, or may become pregnant during the study, and that this will not affect their continued participation. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| United States | Kaiser Permanente of Colorado | Denver | Colorado |
| Lead Sponsor | Collaborator |
|---|---|
| Kaiser Permanente | InterVision, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Oregon Research Institute |
United States,
Estabrooks PA, Nelson CC, Xu S, King D, Bayliss EA, Gaglio B, Nutting PA, Glasgow RE. The frequency and behavioral outcomes of goal choices in the self-management of diabetes. Diabetes Educ. 2005 May-Jun;31(3):391-400. — View Citation
Glasgow RE, Bull SS, Piette JD, Steiner JF. Interactive behavior change technology. A partial solution to the competing demands of primary care. Am J Prev Med. 2004 Aug;27(2 Suppl):80-7. Review. — View Citation
Glasgow RE, Nelson CC, Strycker LA, King DK. Using RE-AIM metrics to evaluate diabetes self-management support interventions. Am J Prev Med. 2006 Jan;30(1):67-73. — View Citation
Glasgow, R.E., Nutting, P.A. (2004) Diabetes. Handbook of Primary Care Psychology. L. Haas (Editor) Oxford University Press, New York, pp 299-319.
King DK, Estabrooks PA, Strycker LA, Toobert DJ, Bull SS, Glasgow RE. Outcomes of a multifaceted physical activity regimen as part of a diabetes self-management intervention. Ann Behav Med. 2006 Apr;31(2):128-37. — View Citation
King, D.K., Glasgow, R.E. (2004) Self-management of Type 2 Diabetes: Key Issues, Evidence-Based Recommendations, and Future Directions. In: Best Practices in the Behavioral Management of Chronic Disease, J. Trafton & William Gordon (Eds.). Institute for Disease Management, Los Altos, CA, Vol 2, Chapter 9.
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Improvement in health behaviors (e.g., dietary patterns, physical activity, medication taking) and biologic outcomes (HbA1c, lipid ratio, blood pressure, and smoking status). | Baseline, 4 months and 12 months | No | |
| Secondary | Diabetes-specific quality of life (Diabetes Distress Scale), patient activation (PAM scale), and perceived social-environmental support (the Chronic Illness Resources Survey) at 4- and 12-month follow-ups. | 4 and 12 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
| Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
| Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
| Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
| Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
| Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
| Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
| Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
| Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
| Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
| Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
| Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
| Completed |
NCT02252224 -
Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance
|